These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-001647-30||An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)||not-yet-due|
|Listed as ongoing, but also has a completion date||2004-001861-17||EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL).||2008-06-27||bad-data|
|Completed, but no date||2006-001549-32||Prospectic, multicentric, randomized, controlled trial for the evaluation of efficacy of Caspofungin vs Amfotericina B liposomiale for the empirical treatment of the FUO in children neutropenic for an...||bad-data|
|Completed, but no date Terminated||2006-005673-21||PROTOCOL OF DIAGNOSIS AND THERAPY FOR RETINOBLASTOMA - AIEOP RB 05||bad-data|
|Ongoing||2008-002311-40||ICC APL STUDY 01 TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA||not-yet-due|
|Ongoing||2010-019224-31||INTERGROUP TRIAL FOR CHILDREN OR ADOLESCENTS WITH B-CELL NHL OR B-AL: EVALUATION OF RITUXIMAB EFFICACY AND SAFETY IN HIGH RISK PATIENTS||not-yet-due|
|Other||2010-021396-81||European Low and Intermediate Risk Neuroblastoma||not-yet-due|
|Other||2011-000990-29||Multinational european trial for children with the opsoclonus myoclonus syndrome/dancing eye syndrome.||not-yet-due|
|Not reported Terminated||2011-006109-85||DIAGNOSTIC AND THERAPEUTIC STUDY FOR NEWLY DIAGNOSED RETINOBLASTOMA PATIENTS RTB AIEOP 012||2018-01-03||due-trials|
|Ongoing||2012-003092-19||Reinduction protocol for patients with high-risk neuroblastoma in first relapse||not-yet-due|
|Ongoing||2014-000652-28||Study Protocol LAM 2013/01||not-yet-due|